Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Groups are compared using the log-rank test, with the corresponding p-values being at the top right of each graph
Current research status Retatrutide is currently in Phase 3 clinical trials, with Eli Lilly conducting multiple large-scale studies
Its broad gene-modulating activity profile in transcriptomic research has made it a widely referenced compound across dermatological, regenerative, and aging-related research fields
But here's the thing: the tripeptide's biological effects persist well beyond its time in the bloodstream
US$ 26.29
US$ 26.66
.webp)
US$ 22.40
US$ 22.88
US$ 23.50
US$ 29.89
